These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2841052)

  • 1. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis.
    Craig JC; Haire M; Merrett JD
    Clin Immunol Immunopathol; 1988 Sep; 48(3):253-60. PubMed ID: 2841052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological control of Epstein-Barr virus-transformed lymphocytes in multiple sclerosis.
    Craig JC; Haire M; Millar JH; Fraser KB; Merrett JD
    Clin Immunol Immunopathol; 1983 Oct; 29(1):86-93. PubMed ID: 6309449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A.
    Irving WL; Jenkins RE; Walker PR; Clayden SA; Lydyard PM
    Cell Immunol; 1985 Dec; 96(2):245-54. PubMed ID: 3017572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The regulation of B-lymphocyte activity by the Epstein-Barr virus in ankylosing spondylarthritis].
    Peĭcheva V; Kan A; Amor B
    Vutr Boles; 1990; 29(5):88-91. PubMed ID: 1964317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
    Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM
    J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.
    Yarchoan R; Tosato G; Blaese RM; Simon RM; Nelson DL
    J Exp Med; 1983 Jan; 157(1):1-14. PubMed ID: 6294212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell regulation of B-lymphoblastoid cell line function.
    Kempner DH; Leibold W; Gatti RA
    Cell Immunol; 1980 Sep; 55(1):32-41. PubMed ID: 6253086
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
    J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.
    Craig JC; Hawkins SA; Swallow MW; Lyttle JA; Patterson VH; Merrett JD; Haire M
    Clin Exp Immunol; 1985 Sep; 61(3):548-55. PubMed ID: 3000660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of in vitro responses to polyclonal activation of peripheral blood lymphocytes in patients with active sarcoidosis.
    Pasquali JL; Godin D; Urlacher A; Pelletier A; Pauli G; Storck D
    Eur J Clin Invest; 1985 Apr; 15(2):82-8. PubMed ID: 2986985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: a common feature of autoimmune disease.
    Shore A; Klock R; Lee P; Snow KM; Keystone EC
    J Clin Immunol; 1989 Mar; 9(2):103-10. PubMed ID: 2541162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C; Aloisi F
    Front Immunol; 2021; 12():665718. PubMed ID: 34305896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells and multiple sclerosis.
    Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
    Katsuki T; Katsuki K; Imai J; Hinuma Y
    Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.